The development of the technology and capacity for the production of factor VIII for the treatment of hemophilia A.
Aronson
D L
DL
George Washington University Medical Center, Washington, DC.
D000911:Antibodies, Monoclonal / Q000276:immunology; D011232:Chemical Precipitation; D003080:Cold Temperature; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000302:isolation & purification* / Q000627:therapeutic use; D006405:Hematology / Q000379:methods* / Q000639:trends; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D007158:Immunologic Techniques; D011994:Recombinant Proteins; D014775:Virus Activation
D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins; D005169:Factor VIII